Jennifer Christie, MD
Gastroenterology · Aurora, CONPI 1750312252
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $35,127 of the $44,871 with a category attached, or 78.3%. 9 manufacturers reported payments, led by Olympus America Inc. at 38.3% of the total. Reporting peaked in 2023 at $30,407 and has fallen 99.6% since, to $127 in 2025. Among gastroenterology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 68 payments — averaging $659.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus America Inc.$17K
- Olympus Corporation Of The Americas$13K
- Shire North American Group Inc$7K
- Evoke Pharma, Inc.$4K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- Phathom Pharmaceuticals, Inc.$188
- plus $299 from 3 others
Across 285 payments — averaging $443.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$118K
- Bausch Health US, LLC$9K
What the payments were for
- Consulting fees$35,12778%
- Speaking & faculty fees$3,2007%
- Travel & lodging$4,74611%
- Food & beverage$1,7984%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus America Inc. | 24 | $17,189 |
| Olympus Corporation Of The Americas | 21 | $13,191 |
| Shire North American Group Inc | 12 | $6,995 |
| Evoke Pharma, Inc. | 6 | $3,673 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $3,336 |
| Phathom Pharmaceuticals, Inc. | 1 | $188 |
| Johnson & Johnson | 1 | $145 |
| Boston Scientific | 1 | $127 |
| AstraZeneca | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GIMOTI$3,470
- VOQUEZNA$188
- EVIS EXERA lll COLONOVIDEOSCOPE$146
- AKEEGA$145
- GENERAL - BILIARY DEVICES$127
How this compares
$44,871 in reported general payments places this provider in the 90th percentile of 304 gastroenterology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulancePlecanatide | 18 | $6,549 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 14 | $872 |
| Famotidine | 52 | $679 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 38 | $610 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 14 | $399 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Aurora
- Mihir WaghAurora$217K
- Steven EdmundowiczAurora$190K
- Raj ShahAurora$98K
- Hazem HammadAurora$57K
- Mohammad BilalAurora$36K
- Benjamin ClickAurora$35K
- Sachin WaniAurora$31K
- Frank ScottAurora$12K
- Mark GerichAurora$9K
- Ariana GreenwoodAurora$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.